Canadian Minister of Health Rona Ambrose Tuesday announced the launch of Phase 1 clinical trials in human for Canada's Ebola vaccine¹ (VSV-EBOV) at the Walter Reed Army Institute of Research in Silver Spring, the U.S. state of Maryland.

 

The Phase 1 clinical trial will test the vaccine on a small group of people to determine whether the vaccine is safe and the appropriate dose necessary to provide immunity², said Ambrose in a press release. 

 

The vaccine, developed by scientists with the Public Health Agency of Canada's National Microbiology Laboratory and licensed³ to NewLink Genetics, has shown great promise in animal research, Ambrose claimed, saying the vaccine could be an important tool in helping⁴ to control the ongoing⁵ Ebola outbreak in West Africa. 

 

The result of the study are expected in December.

点击收听单词发音